Category Archives: Cancer Research

New Blood Test breakthrough for Prostate Cancer.

Researchers at the Institute of Cancer Research and clinicians at the Royal Marsden Hospital in London have developed a simple three-in-one blood test that could transform treatment of advanced prostate and other cancers. The test pinpoints those men who will respond to treatment with the PARP inhibitor Olaparib. This orally taken drug marketed by AstraZeneca is…
Read more

‘Immunotherapy’ the new cancer treatment buzzword

Harnessing a patient’s immune system to recognize and destroy tumour cells has been the central goal in the past few years of anti-cancer immunotherapy trials. There has been considerable interest in Adopted Cell Transfer, (ACT), where tumour-specific cytotoxic T cells are infused into cancer patients. These recognise, target and destroy cancer cells. ACT is proving…
Read more

Good News for breast cancer sufferers

Image: Tumour Heterogeneity The NHS in UK has finally approved Kadcyla, Roche Pharmaceuticals breast cancer drug, for routine use after a four-year campaign. The drug extends the lives of women with advanced forms of breast cancer by some six months. It was hitherto only available on a case-by-case basis through the Cancer Drugs Fund because…
Read more

‘Breakthrough’ lung cancer drug made available on NHS

Tagrisso, (Osimertinib), a last-chance drug produced by AstraZeneca that can lead to an “unprecedented” reduction in lung cancer tumours is now available on the NHS thanks to the newly updated Cancer Drugs Fund rules which allow a promising drug to be used while still in trial evaluation. The once-a-day tablet will be available immediately for…
Read more